Global contract development and manufacturing organization (CDMO), Recipharm, has completed a new analytical laboratory at its facility in Bengaluru, India. It has been in full operation since August 1, 2021.
 
The new 370 square meter area is fully cGMP compliant and is equipped with state-of-the-art technology and instruments to cater for the rising demand from customers for the company’s stand-alone Recipharm Analytical Solutions.
 
Recipharm Analytical Solutions is designed to help customers with timely, reliable outsourced support for analytical services from concept through to commercial. The new laboratory will accommodate 40 scientists and will bolster the team’s capacity to support additional projects.
 
“It’s great to be able to announce the inauguration of our new analytical laboratory under Recipharm Analytical Solutions,” said Ramesh Jagadeesan, assistant vice president, Recipharm. “Despite all the challenges the pandemic has presented, our team has worked diligently to complete the project and ensure the laboratory is operational, on time. We’re confident the new laboratory will bolster our ability to support our customers and meet their method development, validation and stability studies requirements while maintaining the quality services they’re accustomed to from Recipharm.”
 
Recipharm has also appointed Manivel Thangapragasam as associate director to lead the new laboratory. Manivel brings 21 years of experience in the field of analytical development and stability studies.